Colongan, Shawn Levi C.
HRN: 21-34-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/30/2025
10/06/2025
IV
5ml
TID
AGE
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes